|Year : 2019 | Volume
| Issue : 65 | Page : 592-599
Antioxidant flavonoids from Alhagi maurorum with hepatoprotective effect
Muneera S M. Al-Saleem1, Lamya H Al-Wahaib1, Wael M Abdel-Mageed2, Yaser G Gouda3, Hanaa M Sayed3
1 Department of Chemistry, College of Science, Princess Noura Bint Abdul Rahman University, Riyadh, Saudi Arabia
2 Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut, Egypt
3 Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut, Egypt
|Date of Submission||12-Apr-2019|
|Date of Decision||28-May-2019|
|Date of Web Publication||19-Sep-2019|
Wael M Abdel-Mageed
Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box. 2457, Riyadh 11451
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Alhagi maurorum, commonly used in folk medicine, has been reported to have several biological activities. Objective: We have studied the antioxidant chemical components from A. maurorum to determine their in vitro antiproliferative and hepatoprotective activities. Materials and Methods: The alcoholic extract of A. maurorum root was subjected to a successive solvent fractionation and various chromatographic techniques guided by the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay to isolate their antioxidant active compounds. The structures of the isolated compounds were identified through the extensive use of nuclear magnetic resonance and mass spectroscopy coupled with correlation to known compounds. The antioxidant and cytotoxic activities of the isolated compounds were quantified using DPPH and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assays, respectively. The hepatoprotective activity of each extract and the total flavonoid fraction were assessed quantitatively on carbon tetrachloride (CCl4)-induced hepatotoxicity in rats. Results: Fourteen flavonoids, including four aglycones (1–4) and ten glycosides (5–14), were isolated. The flavonoid glycosides (6–14) are being reported for the first time to our knowledge. The free aglycones, those of the flavonol type, exhibited strong antioxidant and antiproliferative activities. The flavonoid glycosides exhibited weak cytotoxic activity against the hepatocellular carcinoma cell line. The total flavonoid fraction showed the strongest hepatoprotective activity against CCl4-induced hepatotoxicity. Conclusion: A total of 14 flavonoids were identified from A. maurorum; nine of them were isolated for the first time. Flavonoids were the main chemical group identified from the A. maurorum root extracts, and they are responsible for the hepatoprotective activity. The findings set up a scientific explanation for the folkloric administration of A. maurorum in the treatment of hepatic disorders.
Keywords: Alhagi maurorum, antioxidant, cytotoxic, flavonoids, hepatoprotective activity
|How to cite this article:|
M. Al-Saleem MS, Al-Wahaib LH, Abdel-Mageed WM, Gouda YG, Sayed HM. Antioxidant flavonoids from Alhagi maurorum with hepatoprotective effect. Phcog Mag 2019;15:592-9
|How to cite this URL:|
M. Al-Saleem MS, Al-Wahaib LH, Abdel-Mageed WM, Gouda YG, Sayed HM. Antioxidant flavonoids from Alhagi maurorum with hepatoprotective effect. Phcog Mag [serial online] 2019 [cited 2020 Aug 5];15:592-9. Available from: http://www.phcog.com/text.asp?2019/15/65/592/267168
- A total of 14 flavonoids were identified from Alhagi maurorum; nine of them were isolated for the first time
- The free aglycones, those of the flavonol type, exhibited strong antioxidant activity
- The flavonoid glycosides exhibited weak cytotoxic activity against the hepatocellular carcinoma cell line
- The total flavonoid fraction showed the strongest hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity.
Abbreviations used:1H- and13C-NMR: Proton and carbon-13 nuclear magnetic resonance; CC: Column chromatography; TLC: Thin-layer chromatography; RP: Reversed phase; GAE: Gallic acid equivalent; MTT: 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide; QE: Quercetin equivalent; HepG2: Hepatocellular carcinoma; DMSO: Dimethyl sulphoxide; SGOT: Serum glutamate oxaloacetate transaminase; TFAM: Total flavonoids of Alhagi maurorum; DMEM: Dulbecco's Modified Eagle's Medium; ALP: Serum alkaline phosphatase; TB: Total bilirubin; SD: standard deviation; SGPT: Serum glutamate pyruvate transaminase; DMRT: Duncan's multiple range test; LSD: Least significance difference.
| Introduction|| |
Alhagi maurorum Bioss. (Syn. Alhagi camelorum; Alhagi pseudalhagi) (Fabaceae) is an undershrub, glabrous, or pubescent that is 60–100 cm tall. The plant is a preferred food for camels, and thus sometimes called Shoak el-gamal, camelthorn, Agool, and Aqool. It is distributed in Russia, Turkey, Iran, Syria, Afghanistan, Pakistan, and North Africa. It is used in traditional medicine as an appetizer, aphrodisiac, tonic, anti-asthmatic, antirheumatic, diuretic, antipyretic, cholagogue, demulcent, and expectorant. The plant has been widely used as a laxative and in treating a variety of liver disorders and various types of gastrointestinal and urinary tract disorders. Moreover, the oil from its leaves has been used in the treatment of rheumatism.,,,, A literature survey revealed the presence of proanthocyanidins, flavonoids, phenolic acids,,,,,,,, sitosterols, triterpenes,,,, and other chemical constituents. Biological studies included antidiarrheal,, gastroprotective, anti-inflammatory, anti-ulcer, antipyretic,,,,,,, antimicrobial,,,, antioxidant, and diuretic activities.,,
In our continued search for lead compounds derived from natural sources, we worked extensively on the dried underground parts of A. maurorum to characterize their phenolic compounds and potential biological activities. Although various pharmacological activities have been declared for A. maurorum root extract, few deep phytochemical studies have been carried out to explore its main active metabolites and the corresponding biological activities. The purpose of the current study is to assess the antioxidant, cytotoxic, and hepatoprotective activities of the different extracts of A. maurorum and its phenolic metabolites.
| Materials and Methods|| |
1 H (600 MHz) and13 C (150 MHz) NMR experiments were measured in dimethyl sulphoxide (DMSO)-d6 on a Bruker Avance DRX 600 spectrometer (Bruker GmbH, Rheinstetten, Germany). Column chromatography (CC) was carried out on Sephadex LH-20 (25–100 mm mesh size, Sigma-Aldrich, Munich, Germany), Diaion HP-20 (Mitsubishi Chemical Co., Ltd., Tokyo, Japan), RP-18 (Merck, Darmstadt, Germany), and Kieselgel 60 (60–230 mesh, Merck). Purification was carried out using flash medium-pressure liquid chromatography (22 mm, i.d. × 30 cm, Kusano Scientific Co., Tokyo, Japan) and an Agilent 1100 Series separation module high-performance liquid chromatography (HPLC) equipped with Agilent 1200 Series diode array detector and an Agilent Chromatorex Zorbax SB semi-preparative C18 column (5 μm, 9.4 × 250 mm). Precoated silica gel RP-C18F254S and G60 F254(E-Merck) plates were used for thin-layer chromatography (TLC), and 10% H2 SO4 was used as a spraying reagent followed by heating for 3 min.
The soil-free roots of A. maurorum Bioss were collected in 2015 from the field of Assiut governorate during summer. Prof. Dr. G. El-Naggar, Professor of Taxonomy, Botany Department, Faculty of Sciences, Assiut University, identified the plant. A voucher specimen (No. 2015-ALM) was kept in the Herbarium of Pharmacognosy Department, Faculty of Pharmacy, Assiut University, as reference material.
Extraction and isolation
800 g of the powdered plant material was extracted with 70% aqueous ethanol by maceration and percolation (3 L × 3) until exhaustion. The ethanol extract was concentrated under reduced pressure to give 150 g (18.8% w/w) of brown viscous extract. Thereafter, the ethanolic extract (90 g) was blended with 400 mL of distilled water. The mixture was then taken for consecutive solvent fractionation with n-hexane, dichloromethane, and ethyl acetate to yield 9.2 g, 24.3 g, and 27.1 g, respectively. The dichloromethane fraction was subjected to successive normal-phase CC using a gradient CHCl3–MeOH mixture. Four compounds were isolated from the CH2 Cl2 fraction; compounds 4 (19.3 mg), 3 (24.5 mg), 2 (18.6 mg), and 1 (16.11 mg).
The ethyl acetate fraction was applied to normal-phase CC using CHCl3–MeOH mixture via a gradient elution to afford four fractions (F1 to F4). Fraction F2 was subjected to medium pressure liquid chromatography (MPLC) using an RP-18 column and a CH3 CN–H2O gradient followed by RP-HPLC using a gradient of CH3 CN–H2O (0%–100%) over 30 min to afford compounds 12 (12.1 mg), 13 (13.6 mg), and 14 (6.8 mg).
The remaining aqueous fraction (28.1 g) was concentrated under reduced pressure and subjected to a column of Diaion HP-20 and eluted with water; 25%, 50%, and 75% methanol in water; and then 100% methanol, followed by washing with acetone to give 2.5 g (25% MeOH), 6.9 g (50% MeOH), 3.6 g (75% MeOH), and 2.9 g (100% methanol). The 50% MeOH and 75% MeOH fractions were combined (because of the similarities between them visualized on TLC) and were subjected to normal-phase CC using a CHCl3–MeOH gradient affording three fractions (F1 to F3). Fractions F2 and F3 were subjected to RP-HPLC using CH3 CN–H2O gradient elution (0%–100%) over 45 min to give compounds 11 (5.1 mg) and 9 (6.5 mg) from F2 and compounds 7 (4.7 mg), 8 (7.8 mg), and 10 (11.4 mg) from F3. The 100% methanol fraction was subjected on a Sephadex LH-20 column, followed by RP-HPLC using CH3 CN–H2O gradient elution (0%–100%) over 20 min to give compounds 5 (22 mg) and 6 (9.7 mg).
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH3.83 (3H, s, OMe), 6.21 (1H, d, J = 1.5 Hz, H-6), 6.43 (1H, d, J = 1.5 Hz, H-8), 7.86 (1H, d, J = 1.4 Hz, H-2'), 6.91 (1H, d, J = 7.0 Hz, H-5'), 7.51 (1H, dd, J = 7.0, 1.4 Hz, H-6'), and 12.57 (1H, s, 5-OH); sugar moiety: dH0.91 (3H, d, J = 6.2 Hz, H-6''' rham), 3.05–3.71 (10H, m, other sugar protons), 4.41 (1H, br.s, H-1''' rham), and 5.43 (1H, d, J = 7.5 Hz, H-1'' glc).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
|Table 1: Carbon-13 nuclear magnetic resonance data of compounds (5-14), 150 MHz in dimethyl sulphoxide-d6|
Click here to view
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH3.85 (3H, s, OMe), 6.12 (1H, br.s, H-6), 6.34 (1H, br.s, H-8), 7.99 (1H, br.s, H-2'), 6.89 (1H, d, J = 7.0 Hz, H-5'), 7.49 (1H, br.d, J = 7.0 Hz, H-6'), and 12.54 (1H, s, 5-OH); sugar moiety: dH1.05 (3H, d, J = 6.1 Hz, H-6''' rham), 3.07–3.71 (10H, m, other sugar protons), 4.42 (1H, br.s, H-1''' rham), and 5.42 (1H, d, J = 6.8 Hz, H-1'' gal).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH6.17 (1H, br.s, H-6), 6.37 (1H, br.s, H-8), 7.48 (1H, d, J = 1.7 Hz, H-2'), 6.80 (1H, d, J = 7.1 Hz, H-5'), 7.67 (1H, dd, J = 7.1, 1.7 Hz, H-6'), and 12.70 (1H, s, 5-OH); sugar moiety: dH0.79, (3H, d, J = 6.1 Hz, H-6'''' rham), 1.05 (3H, d, J = 6.2 Hz, H-6''' rham), 3.03–3.82 (13H, m, other sugar protons), 3.80 (1H, m, H-2 gal), 4.38 (1H, br.s, H-1'''' rham), 5.05 (1H, br.s, H-1''' rham), and 5.57 (1H, d, J = 6.9 Hz, H-1'' gal).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH6.15 (1H, br.s, H-6), 6.38 (1H, br. s, H-8), 8.03 (2H, d, J = 7.4 Hz, H-2', 6'), 6.85 (2H, d, J = 7.4 Hz, H-3', 5'), and 12.67 (1H, s, 5-OH); sugar moiety: dH0.77 (3H, d, J = 6.0 Hz, H-6'''' rham), 1.04 (3H, d, J = 6.1 Hz, H-6''' rham), 3.08–3.73 (13H, m, other sugar protons), 3.77 (1H, m, H-2 gal), 4.35 (1H, br.s, H-1'''' rham), 5.04 (1H, br.s, H-1''' rham), and 5.54 (1H, d, J = 6.9 Hz, H-1'' gal).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH3.84 (3H, s, OMe), 6.17 (1H, br.s, H-6), 6.39 (1H, br.s, H-8), 7.84 (1H, d, J = 1.5 Hz, H-2'), 6.89 (1H, d, J = 7.0 Hz, H-5'), and 7.48 (1H, dd, J = 7.0, 1.5 Hz, H-6'); sugar moiety: dH0.70 (3H, d, J = 6.0 Hz, H-6'''' rham), 0.95 (3H, d, J = 5.9 Hz, H-6''' rham), 3.03–3.72 (13H, m, other sugar protons), 3.45 (1H, m, H-2 glu), 4.37 (1H, br.s, H-1'''' rham), 5.02 (1H, br.s, H-1''' rham), and 5.61 (1H, d, J = 7.4 Hz, H-1'' glc).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH3.87 (3H, s, OMe), 6.17 (1H, d, J = 1.2 Hz, H-6), 6.41 (1H, d, J = 1.2 Hz, H-8), 8.00 (1H, d, J = 1.5 Hz, H-2'), 6.89 (1H, d, J = 7.1 Hz, H-5'), 7.49 (1H, dd, J = 7.1, 1.5 Hz, H-6'), and 12.65 (1H, s, 5-OH); sugar moiety: dH0.70 (3H, d, J = 6.0 Hz, H-6'''' rham), 1.04 (3H, d, J = 6.1 Hz, H-6''' rham), 3.06–3.76 (13H, m, other sugar protons), 3.80 (1H, m, H-2 gal), 4.39 (1H, br.s, H-1'''' rham), 4.98 (1H, br.s, H-1''' rham), and 5.66 (1H, d, J = 6.9 Hz, H-1'' gal).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH3.84 (3H, s, OMe), 6.45 (1H, d, J = 1.4 Hz, H-6), 6.78 (1H, d, J = 1.4 Hz, H-8), 7.87 (1H, d, J = 1.6 Hz, H-2'), 6.91 (1H, d, J = 7.0 Hz, H-5'), and 7.55 (1H, dd, J = 7.0, 1.6 Hz, H-6'); sugar moiety: d 0.97 (3H, d, J = 5.9 Hz, H-6''' rham), 3.04–3.71 (16H, m, other sugar protons), 4.41 (1H, br.s, H-1''' rham), 5.06 (1H, d, J = 7.2 Hz, H-1'''' glc), and 5.46 (1H, d, J = 7.4 Hz, H-1'' glc).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH8.43 (1H, s, H-2), 6.46 (1H, d, J = 2.0 Hz, H-6), 6.71 (1H, d, J = 2.0 Hz, H-8), 7.40 (2H, d, J = 7.0 Hz, H-2', 6'), 6.82 (2H, d, J = 7.0 Hz, H-3', 5'), 9.63 (1H, s, 4'-OH), and 12.93 (1H, s, 5-OH); sugar moiety: dH3.16–3.71 (6H, m, sugar protons) and 5.05 (1H, d, J = 7.3 Hz, H-1'' glc).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH3.78 (3H, s, OMe), 8.44 (1H, s, H-2), 6.46 (1H, d, J = 1.5 Hz, H-6), 6.71 (1H, d, J = 1.5 Hz, H-8), 7.15 (1H, d, J = 1.0 Hz, H-2'), 6.81 (1H, d, J = 6.5 Hz, H-5'), 6.99 (1H, dd, J = 6.5, 1.0 Hz, H-6'), 9.18 (1H, s, 4'-OH), and 12.90 (1H, s, 5-OH); sugar moiety: dH3.14–3.70 (6H, m, sugar protons) and 5.05 (1H, d, J = 7.4 Hz, H-1'' glc).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
1 H NMR data (600 MHz, DMSO-d6): aglycone: dH5.48 (1H, dd, J = 13.5, 2.8 Hz, H-2), 2.72 (1H, dd, J = 16.9, 2.8 Hz, H-3 eq), 3.32 (1H, m, H-3 ax), 6.11 (1H, d, J = 1.9 Hz, H-6), 6.13 (1H, d, J = 1.9 Hz, H-8), 7.31 (2H, d, J = 7 Hz, H-2', 6'), 6.78 (2H, d, J = 7 Hz, H-3', 5'), 9.61 (1H, br. s, 4'-OH), and 11.99 (1H, br. s, 5-OH); sugar moiety: dH3.12–3.67 (6H, m, sugar protons) and 4.96 (1H, d, J = 7.5 Hz, H-1'' glc).13 C NMR data (150 MHz, DMSO-d6) [Table 1].
Acid hydrolysis of isolated flavonoid glycosides
3 mg of the isolated flavonoid glycosides was dissolved in 5 mL of HCl (2 M) and refluxed for 2 h. The reaction mixture was left to cool and then shaken with 2 mL of ethyl acetate thrice to extract the aglycone part, leaving the sugar parts in the aqueous layer. The sugars were identified by comparison with authentic samples, adopting the procedure of Abdel-Mageed et al., 2014.
Determination of total phenolic content
Folin–Ciocalteu reagent method was used to ascertain the amount of total phenolics in the different extracts of A. maurorum leaves. In a test tube, a mixture of 0.5 mL of various A. maurorum extracts (1 mg/mL) was mixed with 2.0 mL of sodium carbonate (2%, w/v) and 2.5 mL of Folin–Ciocalteu reagent 10% (V/V) and then incubated with intermittent shaking at 45°C for 15 min. The absorbance was noted at 765 nm, and the calibration curve was prepared utilizing gallic acid as a standard. The results were expressed as gallic acid equivalents in milligrams per gram of dried extract.
Quantitative estimation of total flavonoids
The content of total flavonoid in the different extracts of A. maurorum was determined based on the formation of a flavonoid–aluminum complex, adopting the procedure described by Sen et al., 2013, where 0.1 mL of 1 mol/L potassium acetate, 0.1 mL of 10% aluminum nitrate, and 4.3 mL of 80% ethanol were mixed with 0.5 mL of various solvent extracts (1 mg/mL) and incubated for 40 min at 23°C until a yellow color developed indicating the presence of a flavonoid. The absorbance of each extract was measured at 415 nm, and quercetin was used as a standard material. Different concentrations of quercetin solutions were prepared to create the standard calibration curve, and the results for each extract were expressed as quercetin equivalents in milligram per gram of dried extract.,
Preparation of the total flavonoids of Alhagi maurorum
The alcoholic extract (20 g) was dissolved in hot water and then alkalinized with 5% sodium carbonate to pH 9–10. The process was followed by removal of lipophilic constituents by consecutive extractions with chloroform. Thereafter, hydrochloric acid (1 N) was used to acidify the remaining aqueous extract to pH 4. The total flavonoids of A. maurorum (TFAM) preparation was carried out adopting the procedure described by Wu et al., 2006. A dark brown powder (4.5 g) was obtained which was considered as the TFAM.
1,1-dipheny l-2-picrylhydrazyl radical-scavenging assay
The radical-scavenging activities of the isolated compounds were qualitatively and quantitatively assessed against 0.2% 1,1-diphenyl-2-picrylhydrazyl (DPPH)* in MeOH according to previously described methods, using ascorbic acid as a positive control.
3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide cytotoxic assay
The hepatocellular carcinoma (HepG2) cells, obtained from the American Type Culture Collection (Manassas, VA, USA), were sustained and cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 2 mM L-glutamine, 10% fetal bovine serum, and antibiotics (0.10 g/L streptomycin and 0.06 g/L penicillin – Sigma-Aldrich, Munich, Germany) at 95% humidity, 5% CO2, and 37°C. Solutions of the isolated flavonoids were prepared at different concentrations in 0.1% DMSO solution. The 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) colorimetric assays were used to assess thein vitro antiproliferative action of the isolated flavonoids against HepG2, adopting the procedure described by Ge et al., 2018. Doxorubicin was chosen as a positive control to evaluate cytotoxicity.
Male albino rats (78 in total) of Wistar albino strain of similar age (8–10 weeks) and weight (150–200 g) were obtained from the Experimental Animal Center, College of Pharmacy, King Saud University. The conditions at which the animals were housed were kept at constant levels: humidity (55%), temperature (23°C ± 2°C), and (12/12 h) light/dark conditions. They had free access to drinking water ad libitum and were supplied with Purina chow. The institutional animal ethics committee approved the animal experimental protocol for this study.
Thirteen groups of male Wistar rats containing six animals each were designed. Normal saline was provided to Group I and was marked as the negative control group. The other groups (II–XIII) received carbon tetrachloride (CCl4) (0.1 mL) in liquid paraffin (1:1) intraperitoneally per 100 g body weight. Group II was administered only the CCl4 treatment. Group III was given silymarin (Sigma, St. Louis, MO, USA) through oral administration (p.o.) at a dose of 20 mg/kg. Groups (IV-XI) were treated with 250 and 500 mg/kg of the different A. maurorum extracts, whereas Groups XII and XIII were treated with 150 and 300 mg/kg of the TFAM fraction, respectively. Drugs were administered 5 days prior to the CCl4 application and were continued until completion of the experiment. Ether anesthesia was used to sacrifice the animals after 24 h of CC14 administration. Blood samples were collected and centrifuged at 3000 rpm for 5 min and then stored at −20°C for evaluation of the biochemical parameters. For the purpose of histopathological investigation, the livers were instantly removed and fixed in 10% formalin.
As per the standard protocols of Edwards and Bouchier, 1991, the serum enzymatic parameters, such as alkaline phosphatase (ALP), serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), as well as the nonenzymatic parameters, such as total bilirubin (TB), were assayed. Diagnostic strips (Reflotron, Roche Diagnostics, Mannheim, Germany) were used to measure the enzymatic activity reading on a Reflotron® Plus instrument (ROCHE).
A one-way analysis of variance technique was used to analyze the data statistically. The values were depicted as means ± standard deviations. Duncan's multiple range test and the least significance difference test facilitated comparison of the significance levels of the means. The level of significance was set at P < 0.05, P < 0.01, and P < 0.001.,
For histopathological assessments, the livers were removed instantly just after the sacrifice of the treated animals, and a small piece of each liver was fixed in 10% buffered neutral formalin for 12 h for use. All specimens were immersed in different concentrations of ethanol, which ranged from 70% to 100%, followed by xylene (3 times, 1 h and each) and finally paraffin wax (4 times, 1 h and each) for dehydration, clearing, and infiltration. Sections of thickness 3–4 μm were cut by a Leitz 1512 rotary microtome (Ernst Leitz Wetlzar, Rockleigh, NJ, USA) and were stained with Mayer's hematoxylin solution for 15 min. Thereafter, the slides were washed with distilled water and then by 80% ethyl alcohol for 1–2 min. Finally, staining was performed with eosin-phloxine solution for 2 min. Light microscopy revealed the histopathological changes.
| Results|| |
The phytochemical investigation of the root extract of A. maurorum, guided by the findings of antioxidant radical scavenging assay, led to the isolation and identification of 14 flavonoids (1-14), including four free aglycones: quercetin (1), isorhamnetin (2), kaempferol (3), naringenin (4) and ten glycosides: isorhamnetin-3-O-rutinoside (5), isorhamnetin-3-O-α-L-rhamnopyranosyl-(1→6)-β-D-galactopyranoside (isorhamnetin 3-robinobioside) (6), quercetin-3-O-(2,6-di-O-α-L-rhamnopyranosyl-β-D-galactopyranoside) (alcesefoliside) (7), kaempferol-3-O-α-L-rhamnopyranosyl-(1→6)-[α-L-rhamnopyranosyl-(1→2)]-β-D-galactopyranoside (mauritianin) (8), isorhamnetin 3-O-(2,6-di-O-α-rhamnosyl)-β-D-glucopyranoside (typhaneoside) (9), isorhamnetin 3-O-(2,6-di-O-α-rhamnosyl)-β-D-galactopyranoside (10), isorhamnetin-3-O-rutinoside-7-O-glucopyranoside (11), genistin (12), 3'-O-methylorobol 7-O-β-D-glucoside (13), and naringenin-7-glucopyranoside (14) [Figure 1]. All structures were identified using extensive NMR analyses [Table 1], accurate mass measurements, and comparisons to published data.
DPPH radical scavenging assay was used to quantify the antioxidant activity of the isolated flavonoids. The findings [Table 2] reveal that all the isolated flavonoids demonstrate significant free radical scavenging activity of variable potency. The free flavonol aglycones (1–3) have the strongest antioxidant activity. Quercetin (1) was identified as the most potent flavonoid with an IC50 value of 10.1 μM.
|Table 2: Antioxidant and cytotoxic activities of the isolated compounds (1-14)|
Click here to view
For thein vitro antihepatoma activity, the MTT colorimetric assay was used to assess the isolated compounds against human HepG2 cells in the presence of doxorubicin as a positive control [Table 2]. Compounds 1 and 3
(quercetin and kaempferol) exhibited the strongest antihepatoma activity with IC50s values of 18.9 and 35.7 μM, respectively [Table 2].
The hepatoprotective activities of different A. maurorum extracts and TFAM were assessed against the chemical injury in the liver cells (hepatocytes) induced by the classical hepatotoxic agent CCl4. Hepatic toxicity induced by the intraperitoneal injection of a single dose of CCl4 is reflected by a significant elevation of biochemical parameter such as SGPT, ALP, SGOT, and TB accompanied by severe damage of hepatic cells, biliary obstruction, and transport inability, in comparison with the control group.
Pretreatment of rats with silymarin significantly reduced the observed elevation in SGPT, SGOT, ALP, and bilirubin induced by CCl4(76.9, 68.0, 49.3 and 77.1%, respectively, P < 0.001) [Table 3], indicating a good recovery from the hepatotoxic effect of CCl4. Pretreatment with A. maurorum total extract and its subfractions (chloroform, ethyl acetate, and aqueous) showed a significant reduction of the biochemical parameters in a dose-dependent manner. The maximum hepatoprotective effect was observed with the aqueous extract at a dose of 500 mg/kg with 58.8, 64.3, 48.9, and 55.6% reduction in the biochemical parameters SGPT, ALP, SGOT, and bilirubin levels, respectively (P < 0.01). Moreover, the oral pretreatment of rats with the TFAM significantly ameliorated the increases observed in SGPT, SGOT, ALP, and TB (69.1, 62.4, 43.6, and 60.7%, respectively) at a dose of 300 mg/kg (P < 0.01) [Table 3].
|Table 3: Effects of the different Alhagi maurorum extracts on the various serum biochemical parameters in rats|
Click here to view
Based on the results observed in the biochemical parameters presented above, the livers of rats pretreated with TFAM were subjected to histological study. The histological appearance of the hepatic cells [Figure 2] showed that exposure to the hepatotoxic agent CCl4 changes the normal histological appearance [Figure 2]a, with observations of severe hepatic lesions marked by extensive fatty changes and hepatocyte necrosis [Figure 2]b. The pretreatment of rats with silymarin [Figure 2]c and TFAM [Figure 2]f showed a good recovery in the hepatocytes accompanied by the disappearance of necrosis and fatty depositions compared with ethyl acetate [Figure 2]d and aqueous extract [Figure 2]e. The results of the in vivo histopathological examinations proved the significant corrective effects of TFAM on the hepatic lesions induced by CCl4, which is in agreement with the results of the biochemical tests.
|Figure 2: Histopathological appearance of rat liver cells; (a) normal cells; (b) carbon tetrachloride-treated liver cells; (c) carbon tetrachloride- and silymarin-treated liver cells; (d) carbon tetrachloride- and ethyl acetate extract (500 mg/kg)-treated liver cells; (e) carbon tetrachloride- and aqueous extract (500 mg/kg)-treated liver cells; (f ) carbon tetrachloride- and total flavonoids of Alhagi maurorum (300 mg/kg)-treated liver cells|
Click here to view
| Discussion|| |
As part of the ongoing search for the discovery of promising new hepatoprotective and antihepatoma compounds from traditional medicinal plants, we had the opportunity to thoroughly investigate the chemical constituents of A. maurorum. Very few reports have detailed the chemical constituents of A. maurorum in depth, and the majority of these studies have focused on the biological activities of the plant extract, with only a few reports discussing its chemical constituents.
In this study, 14 flavonoids (1–14) were identified from the root extract of A. maurorum, including four free aglycones (1–4) and ten glycoside derivatives (5–14). Compounds 6–14 were reported for the first time from A. maurorum. Our findings demonstrate that the isolated flavonoids possess strong radical-scavenging activity. The findings in [Table 2] reveal that the antioxidant activity of the flavonoids depends on the presence of the ortho-dihydroxy (catechol) structure, as found in compounds 1 and 7; the presence of a 2,3-double bond and a 4-oxo function, as found in compounds 1–3; and a 3-hydroxy-4-keto and/or 5-hydroxy-4-keto conformation. Glycosylation of the free hydroxyl group at C-3 (β-hydroxyketone) may reduce the antioxidant activity. The absence of a 2,3-double bond and a 3-hydroxyl group dramatically decreases the antioxidant activity, as in compounds 4 and 14.
Regarding the cytotoxic effect, all the isolated glycosides exhibited weak antiproliferative activity on the human hepatocellular carcinoma cell line HepG2 compared with the corresponding free aglycones. Moreover, the flavonols, in general, exhibited the strongest antiproliferative activity, followed by isoflavones (12, 13) and finally, the flavanones (4, 14). The strongest inhibitory effect was observed with quercetin (1), with an IC50 value of 18.9 μM.
The hepatoprotective activities of the different A. maurorum extracts and the TFAM fraction were evaluated against the hepatotoxic agent CCl4[Figure 2]. Numerous studies have validated that metabolism of CCl4 in the liver results in the production of a highly reactive trichloromethyl radical that alters the cell membrane morphology and function. The modes of action of the free radicals include auto-oxidation of the fatty acids present in the cytoplasmic membrane phospholipids. An elevation in the biochemical parameters such as SGPT, ALP, SGOT, and TB marks the presence of hepatic injury.
The oral administration of the different A. maurorum extracts and the TFAM fraction reduced the biochemical parameters and exhibited hepatoprotective effects in a dose-dependent manner. The strongest hepatoprotective effect was observed with the oral preadministration of TFAM (300 mg/kg), which was still less effective than the silymarin that was used as a reference drug [Figure 3]. The mechanism of such hepatoprotective activity is likely a result of the strong inhibition of the generation of free radicals and antioxidant activity, by the flavonoids and phenolic content. Neutralizing reactive oxygen species, either by nonenzymatic mechanisms and/or enzymatic mechanisms (through enhancement of the activities of the natural hepatic-antioxidant enzymes), may be the main mechanism of TFAM against CCl4-induced injury., Thus, the quantitative estimation of the flavonoid content [Table 4] could explain the hepatoprotective efficiency order of the different extracts as follows: aqueous extract > ethyl acetate extract > chloroform extract.
|Figure 3: Effects of different Alhagi maurorum extracts and total flavonoids of Alhagi maurorum fraction on the serum biochemical parameter: (a) serum glutamate pyruvate transaminase, (b) serum glutamate oxaloacetate transaminase, (c) alkaline phosphatase, and (d) bilirubin|
Click here to view
|Table 4: Quantitative estimation of the total phenolics and flavonoids in mg/g of Alhagi maurorum extracts|
Click here to view
| Conclusion|| |
In the current study, 14 compounds were identified from the root extract of A. maurorum, nine of which (6–14) were isolated for the first time. Free flavonoid aglycones, in particular, of the flavonol type, exhibited stronger antioxidant and cytotoxic activities than the flavonoid glycosides. The total flavonoid fraction (TFAM) showed the highest hepatoprotective activity, followed by the aqueous fraction, whereas the chloroform fraction exhibited the weakest effect. These data set up a scientific explanation for the traditional administration of A. maurorum in the treatment of general hepatic disorders. Thus, it can be concluded that A. maurorum is a promising hepatoprotective agent because of the antioxidant chemicals it contains.
Financial support and sponsorship
This work was funded by the deanship of scientific research at Princess Nourah bint Abdulrahman University, through the Research Group Program Grant no RGP-1440-0014.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Hamed A, Perrone A, Mahalel U, Oleszek W, Stochmal A, Piacente S. Oleanane glycosides from the roots of Alhagi maurorum
. Phytochem Lett 2012;5:782-7.
Nasir E, Ali SI. The Flora of West Pakistan. Dept. of Botany, University of Karachi; 1973. p. 319.
Arshad M, Akbar G, Rashid S. Wealth of medicinal plants of Cholistan desert, Pakistan: Conservational strategies. Hamdard Med 2002;45:25-34.
Brown D. Encyclopedia of Herbs and Their Uses. London: Dorling, Kindersley; 1995. p. 20.
Boulos L. Medicinal Plants of North Africa. Algonac, Michigan: Reference Publications, Inc.; 1983. p. 368.
Awaad AA, Maitland DJ, Soliman GA. Antiulcerogenic activity of Alhagi maurorum
. Pharm Biol 2006;44:292-6.
Naseri MK, Mard SA. Gastroprotective effect of Alhagi maurorum
on experimental gastric ulcer in rats. Pak J Med Sci 2007;23:570-3.
Shaker E, Mahmoud H, Mnaa S. Anti-inflammatory and anti-ulcer activity of the extract from Alhagi maurorum
(camelthorn). Food Chem Toxicol 2010;48:2785-90.
Alimova DF, Kuliev ZA, Nishanbaev SZ, Vdovin AD, Abdullaev ND, Aripova SF. New oligomeric proanthocyanidins from Alhagi pseudalhagi
. Chem Nat Compd 2010;46:352-6.
Sultan A, Moohammadnor M, Eshbakova KA. Chemical constituents of Alhagi pseudalhagi
. Chem Nat Compd 2011;47:140-1.
Laghari AH, Memon S, Nelofar A, Khan KM, Yasmin A, Syed MN, et al
. A new flavanenol with urease-inhibition activity isolated from roots of manna plant camelthorn (Alhagi maurorum
). J Mol Struct 2010;965:65-7.
Li N, Zhang G, Xiong Y, Makhabel B, Li X, Jia X. New isoflavonolignan with quinone reductase inducing activity from Alhagi pseudalhagi
(M.B.). Fitoterapia 2010;81:1058-61.
Ahmad S, Ahmad I, Saleem M, Nisar-Ur-Rehman A, Saeed-Ul-Hassan S, Akhtar KS, et al
. Secondary metabolites from Alhagi maurorum
. J Chem Soc Pak 2009;31:960-3.
Muhammad G, Hussain MA, Anwar F, Ashraf M, Gilani AH. Alhagi
: A plant genus rich in bioactives for pharmaceuticals. Phytother Res 2015;29:1-13.
Ahmad S, Riaz N, Saleem M, Jabbar A, Nisar-Ur-Rehman A, Ashraf M. Antioxidant flavonoids from Alhagi maurorum
. J Asian Nat Prod Res 2010;12:138-43.
Singh VP, Yadav B, Pandey VB. Flavanone glycosides from Alhagi pseudalhagi
. Phytochemistry 1999;51:587-90.
Laghari AH, Memon S, Nelofar A, Khan KM. Alhagi maurorum
: A convenient source of lupeol. Ind Crop Prod 2011;34:1141-5.
Marashdah MS, Mudawi BM, AL-Hazimi HM, Abdallah MA. New aliphatic ketone and new aliphatic ester from the roots of Alhagi maurorum
Medik. J Saudi Chem Soc 2006;10:509-14.
Atta AH, Mouneir SM. Antidiarrhoeal activity of some Egyptian medicinal plant extracts. J Ethnopharmacol 2004;92:303-9.
Kumar R, Sharma RJ, Bairwa K, Roy RK, Kumar A. Pharmacological review on natural antidiarrhoel agents. Pharm Chem 2010;2:66-93.
Neamah NF. A pharmacological evaluation of aqueous extract of Alhagi maurorum
. Glob J Pharmacol 2012;6:41-6.
Awaad AS, El-Meligy RM, Qenawy SA, Atta AH, Soliman GA. Anti-inflammatory, antinociceptive and antipyretic effects of some desert plants. J Saudi Chem Soc 2011;15:367-73.
Islam MW, Zakaria MN, Radhakrishnan R, Chan K, Al-Attas A. Effect of Alhagi maurorum
Medilc. (Leguminosae) on acute gastric lesions in rats. 1st
International Congress on Traditional Medicine and Materia Medica. Tehran; 2000.
Zakaria MN, Islam MW, Radhakrishnan R, Chen HB, Ismail A, Chan K, et al
. Pharmacological evaluation of anti-inflammatory activity of Alhagi maurorum
. J Pharm Pharmacol 1999;51:118.
Zain ME, Awaad AS, Al-Outhman MR, El-Meligy RM. Antimicrobial activities of Saudi Arabian desert plants. Phytopharmacology 2012;2:106-13.
Abdel-Rahman SM, Abd-Ellatif SA, Deraz SF, Khalil AA. Antibacterial activity of some wild medicinal plants collected from Western Mediterranean coast, Egypt: Natural alternatives for infectious disease treatment. Afr J Biotechnol 2011;10:10733-43.
Ramadan MA, Safwat NA. Antihelicobacter activity of a flavonoid compound isolated from Desmostachya bipinnata
. Aust J Basic Appl Sci 2009;3:2270-7.
Bonjar S. Evaluation of antibacterial properties of some medicinal plants used in Iran. J Ethnopharmacol 2004;94:301-5.
Oskoueian A, Oskoueian E, Hendra R, Zohorian F, Samadi F, Karimi E. Antioxidant activity and bioactive compounds in Alhagi maurorum
. Clin Biochem 2011;44:S343-4.
Atta AH, Nasr SM, Mouneir SM, Alwabel NA, Essawy SS. Evaluation of the diuretic effect of conyza dioscorides and Alhagi maurorum
. Int J Pharm Pharm Sci 2010;2:162-5.
Ghane M, Badiei KH, Haji Mohammadi A, Mallah AR. Diuretic effect of Alhagi maurorum
in Goat. 1st
international Congress of Veterinary Pharmacology and Pharmaceutical Sciences (1st
ICVPS), 4, 5 October 2008. Tehran, Iran; 2008.
Marashdah MS, Al-Hazimi HM. Pharmacological activity of ethanolic extract of Alhagi maurorum
roots. Arab J Chem 2010;3:39-42.
Abdel-Mageed WM, Bayoumi SA, Radwan AA, Salem-Bekhit MM, Abd-Alrahman SH, Basudan OA, et al.Simmondsia chinensis
: A rich source of bioactive flavonoids and lignans. Ind Crops Prod 2014;60:99-103.
Aiyegoro OA, Okoh AI. Preliminary phytochemical screening and in vitro
antioxidant activities of the aqueous extract of Helichrysum longifolium
D. BMC Complement Altern Med 2010;10:21.
Sen S, De B, Devanna N, Chakraborty R. Total phenolic, total flavonoid content, and antioxidant capacity of the leaves of Meyna spinosa
roxb. an Indian medicinal plant. Chin J Nat Med 2013;11:149-57.
Asokkumar K, Umamaheswari M, Baharudeen A, Sivashanmugam AT, Subhdhradevi V, Ravi TK. Antioxidant and hepatoprotective activities of the fractions of Ficus microcarpa
using in vitro
and ex vivo
models. Funct Plant Sci Biotechnol 2010;4:17-27.
Wu Y, Wang F, Zheng Q, Lu L, Yao H, Zhou C, et al.
Hepatoprotective effect of total flavonoids from Laggera alata
against carbon tetrachloride-induced injury in primary cultured neonatal rat hepatocytes and in rats with hepatic damage. J Biomed Sci 2006;13:569-78.
Ge L, Li J, Wan H, Zhang K, Wu W, Zou X, et al
. Novel flavonoids from Lonicera japonica
flower buds and validation of their anti-hepatoma and hepatoprotective activity in vitro
studies. Ind Crops Prod 2018;125:114-22.
Ahmed B, Al-Howiriny TA, Siddiqui AB. Antihepatotoxic activity of seeds of Cichorium intybus
. J Ethnopharmacol 2003;87:237-40.
Edwards CR, Bouchier IA. Davidson's Principles and Practice Medicine. London, UK: Churchill Livingstone Press; 1991. p. 492.
Steel RG, Torrie JH. Principles and Procedures of Statistics. 2nd
ed. Singapore: McGraw Hill Book Co.; 1984. p. 172-7.
Akhtar MS, Habib A, Ali A, Bashir S. Isolation, identification and in vivo
evaluation of flavonoid fractions of chloroform/methanol extracts of Rheum emodi
roots for their hepatoprotective activity in Wistar rats. Int J Nutr Pharmacol Neurol Dis 2016;6:28-34. [Full text]
Yang XW, Teng J. Chemical constituents of the unripe fruits of Evodia rutaecarpa
. J Chin Pharm Sci 2007;16:20-3.
Napolitano JG, Lankin DC, Chen SN, Pauli GF. Complete 1H NMR spectral analysis of ten chemical markers of Ginkgo biloba
. Magn Reson Chem 2012;50:569-75.
Guzel A, Aksit H, Elmastas M, Erenler R. Bioassay-guided isolation and identification of antioxidant flavonoids from Cyclotrichium origanifolium
(Labill.) Manden and Scheng. Pharmacogn Mag 2017;13:316-20.
Yeskaliyeva B, Mesaik MA, Abbaskhan A, Kulsoom A, Burasheva GS, Abilov ZA, et al.
Bioactive flavonoids and saponins from Climacoptera obtusifolia
. Phytochemistry 2006;67:2392-7.
Williams JD, Wojcińska M, Calabria LM, Linse K, Clevinger JA, Mabry TJ. The flavonoids and phenolic acids of the genus silphium and their chemosystematic value. Nat Prod Commun 2009;4:435-46.
Yasukawa K, Ogawa H, Takido M. Two flavonol glycosides from Lysimachia nummularia
. Phytochemistry 1990;29:1707-8.
Dini I, Carlo TG, Dini A. Phenolic constituents of Kancolla seeds. Food Chem 2003;84:163-8.
Tai ZG, Cai L, Dai L, Sun WJ, Zhe W, Yang YB, et al
. Antioxidant activities of Caragana sinica
flower extracts and their main chemical constituents. Molecules 2010;15:6722-32.
Hawas UW, Abou El-Kassem LT, Shaher F, Al-Farawati R.In vitro
inhibition of hepatitis C virus protease and antioxidant by flavonoid glycosides from the Saudi costal plant Sarcocornia fruticosa
. Nat Prod Res 2018; 1-8. doi: 10.1080/14786419.2018.1477153.
Aquino R, Behar I, D'Agostino M, De Simone F, Schettino O, Pizza C. Phytochemical investigation on Mercurialis annua
. Biochem Syst Ecol 1987;15:667-9.
Caligiani A, Palla G, Maietti A, Cirlini M, Brandolini V 1H NMR fingerprinting of soybean extracts, with emphasis on identification and quantification of isoflavones. Nutrients 2010;2:280-9.
Viscardi P, Reynaud J, Raynaud J. A new isoflavone glucoside from the flowers of Cytisus scoparius
link. (Leguminosae). Pharmazie 1984;39:781.
Ragab EA, Hosny M, Kadry HA, Ammar HA. Flavanone glycosides from Gleditsia caspica
. India J Nat Prod 2010;3:35-46.
Lata S, Mittal SK. In vitro
and in vivo
hepatoprotective activity of flavonoids rich extracts on Cucumis dipsaceus
Ehrenb. (Fruit). Int J Pharmacol 2017;13:563-72.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3], [Table 4]